Health Events Local 2026-01-14T01:22:49+00:00

Mexico's Microbiota Summit Consolidates Regional Model Based on Evidence and Clinical Application

Yolanda Quintero Gómez, founder and academic director of the Mexico Microbiota Summit, discusses the evolution of the event, its role in promoting a multidisciplinary approach to health, and future projects, including the publication of scientific books.


With nearly three decades of experience in Clinical Nutrition, a consolidated career between Colombia and Mexico, and an academic background integrating public health, education, and microbiota, Yolanda Quintero Gómez has positioned herself as one of the main promoters of the microbiota-nutrition clinical approach in the region.

Quintero emphasized that the event was born out of the absence in the country of a specialized forum on microbiota based strictly on scientific evidence, capable of bringing together nutritionists, doctors, chemists, biologists, microbiologists, psychologists, and other professionals in a multidisciplinary manner, recognizing that microbiota traverses all axes of human health.

The Microbiota Summit, which began in 2023 with a focus on scientific fundamentals throughout the life cycle, has evolved progressively. In this context, she highlighted that no modern therapeutic strategy should exclude the management of the microbiota, given its influence on adherence, treatment response, and prevention of complications.

In an exclusive conversation with LaSalud.mx, nutrition master Yolanda Quintero Gómez explained that her approach to microbiota is not fortuitous, but the result of a sustained clinical practice for almost 30 years, complemented by a specialization in Health Administration with an emphasis on social security, and postgraduate studies, including a master's degree in Microbiota, Probiotics, and Prebiotics at the European University of Madrid and a master's in Education.

In its third edition, it incorporated free research papers, national and international teachers, and a decisive turn towards clinical application, transcending the theoretical plane. For Quintero, this growth reflects the maturity of a science that today allows for concrete intervention in daily medical practice.

From an epidemiological perspective, the specialist emphasized that the microbiota has become a transversal axis in the approach to chronic and metabolic diseases. She pointed out that current scientific evidence demonstrates its impact not only on metabolism but also on the immune, neurological, and clinical systems, which forces us to rethink traditional treatment and prevention models.